No, Bottsy13,
'Tis not I,
wot sold yesterdai,
tho I hope to
unload some
before I do die.
You see, I started investing in Anteo Diagnostics back in 2010. I know two shareholders who have been investors from the early 2000S, and are still shareholders, firm in their conviction that the technology will have many applications. This last quarterly illustrates some of this potential breadth.
So I have been steadily building my investment in the company over the years, including supporting every capital raise, despite the increasing scepticism of my family, for I am quite convinced that such a fundamental chemistry will result in huge advances in technology, advances that support improving living standards, with all of their social benefits (health, food and shelter, education, and progressively, happier and more cooperative societies). My investment, small as it is in terms of the good ship AnteoTech, is akin to the commitment I have given to other personal and professional enterprises in which i have so far engaged. It is not just a stock in which I trade in and out. It is a commitment.
As for yesterday's large volumes, I wouldn't be surprised if a fair bit was trading churn; there are a lot who buy on the good news, as well as those who sell. Some of those traders would buy and sell their own grandmothers. And for every seller, there is a buyer. Undoubtedly there is also trading that doesn't pass the smell test.
But I have not noticed yet on this thread much comment about the content of the Quarterly, which I have read with considerable interest, and am pleased. David has made the point previously, that he makes here: "The Company continues to develop a portfolio approach to the market to ensure that there are multiple future revenue streams that include the high silicon anode, Anteo X and the new separator project." No need to repeat the "highlights"; none is a surprise, although some stand out as clearly moving ahead - e.g. EV1 and prototyping ("moves to evaluate" - hmm?), and EV2 ("scoping a development proposal"). And very glad to see the European appointment well under way - obviously selected candidate - a VP? A very north American title - an eye to the US market? Or a north American native? No, surely a European.
And yesterday's announcement about the SII contract? Well, I'm not surprised, but it has taken a while. Captainblood's comment is noteworthy, about the care shown in the terms of engagement. I can imagine there has been a fair bit of thrashing around about those; I can imagine that a draft contract emanating from a large organisation would express many conditions in its favour, and we have to pull them back from that. I expect the same from the EVs etc. They need to come to recognise that they need the technology, and it takes a while for that to sink in to their management. So I am expecting there is right now much too-ing and fro-ing between AnteoTech and its prospects. Meanwhile, the SII contract sends a strong signal to the Life Sciences market, and will certainly lead to further business with SII. Those contract conditions also serve as a marker, a template for how we will do business.
So, I am pleased, and am resigned to the fact that I will just have to live longer, to enjoy the fruits of my investment - and to see the positive results spilling out into the world.
Good wishes to all of us who sail in the wake of the good ship AnteoTech!
Expand
